Key facts
- It has raised $41.8M; the latest was Later Stage VC ($14.1M) in Dec 2025.
- Notable investors include YuanBio Venture Capital, Peiyang Begonia Fund, Huatai Zijin Investment, Chengdu Venture Capital Group, Tianjin Venture Capital — 17 tracked in total.
- Status: Privately Held (backing).
Investors
17+- ·The complete investor list — 17 names
- ·Watchlist + deal alerts for Horimed
- ·The full record, as it builds
Funding rounds
No funding rounds for Horimed are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Horimed
Manufacturer of optical coherence tomography equipment designed for applied medical uses. The company is mainly engaged in the research and development, production, and sales of Intravascular Ultrasound(IVUS) and Optical Coherence Tomography (OCT) imaging equipment, thereby enabling medical industry users with advanced optical coherence tomography equipment, and providing reliable and efficient products.
- Sector
- Healthcare
- HQ
- Tianjin, China
- Founded
- 2016
- Website
- horimedcare.com/
- Ownership
- Privately Held (backing)
Horimed doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Horimed shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Horimed in its N-PORT filings yet. We sweep new filings monthly.